These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7199669)

  • 1. Beneficial effects of lisuride in Meige disease.
    Micheli F; Fernández Pardal MM; Leiguarda RC
    Neurology; 1982 Apr; 32(4):432-4. PubMed ID: 7199669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment.
    Frattola L; Albizzati MG; Bassi S; Ferrarese C; Trabucchi M
    Acta Neurol Scand; 1982 Aug; 66(2):227-36. PubMed ID: 7136487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Stracke H; Heinlein W; Horowski R; Schatz H
    Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses to lisuride in Meige's disease and chorea.
    Micheli F; Fernandez Pardal MM
    Neurology; 1986 Mar; 36(3):445. PubMed ID: 2936984
    [No Abstract]   [Full Text] [Related]  

  • 5. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
    LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
    Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
    LeWitt PA; Burns RS; Calne DB
    Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine--lisuride cross tolerance.
    Giovannini P; Scigliano G; Grassi MP; Carella F; Parati E; Caraceni T
    Ital J Neurol Sci; 1983 Apr; 4(1):129-30. PubMed ID: 6862842
    [No Abstract]   [Full Text] [Related]  

  • 9. Lisuride in the treatment of Parkinsonism.
    Schachter M; Sheehy MP; Parkes JD; Marsden CD
    Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine and lisuride in dystonias.
    Obeso JA; Luquin MR
    Neurology; 1984 Jan; 34(1):135-6. PubMed ID: 6537848
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral lisuride in Parkinson's disease].
    Obeso JA; Luquin MR; Martínez Lage JM
    Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
    [No Abstract]   [Full Text] [Related]  

  • 12. Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
    Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG; Cozzi R; Chiodini P; Luccarelli G
    N Engl J Med; 1985 Sep; 313(11):656-9. PubMed ID: 4022058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lisuride in parkinsonism.
    Gopinathan G; Teräväinen H; Dambrosia JM; Ward CD; Sanes JN; Stuart WK; Evarts EV; Calne DB
    Neurology; 1981 Apr; 31(4):371-6. PubMed ID: 7194429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.
    Neophytides A; Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Bock J; Walker R
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):261-3. PubMed ID: 7086448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisuride in Parkinson's disease.
    Schachter M; Blackstock J; Dick JP; George RJ; Marsden CD; Parkes JD
    Lancet; 1979 Nov; 2(8152):1129. PubMed ID: 91855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Improvement of Meige syndrome with lisuride].
    Esperança P; Castro-Caldas A
    Acta Med Port; 1985 Jun; 6(6):187-9. PubMed ID: 4083075
    [No Abstract]   [Full Text] [Related]  

  • 17. Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.
    Chiodini P; Liuzzi A; Cozzi R; Verde G; Oppizzi G; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Luccarelli G; Rainer E; Horowski R
    J Clin Endocrinol Metab; 1981 Oct; 53(4):737-43. PubMed ID: 7287863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J; Luquin MR; Obeso JA
    Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.
    Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D
    Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.